| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/22/2026 | ±2.0% | +7.5% | under-priced |
| 07/23/2026 | ±2.9% | -0.5% | over-priced |
| 04/24/2026 | ±3.1% | +3.3% | under-priced |
| 02/12/2026 | ±4.3% | -1.8% | over-priced |
| 10/23/2025 | ±2.8% | +1.6% | over-priced |
| 07/25/2025 | ±3.2% | +1.4% | over-priced |
| 04/28/2025 | ±3.0% | -0.3% | over-priced |
| 02/21/2025 | ±1.6% | -1.8% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $0.96 | $2.4B | $540M |
| Q2 FY2026 | $0.89 | $2.5B | $507M |
| Q1 FY2026 | $0.91 | $2.1B | $519M |
| Q4 FY2025 | — | $2.1B | $518M |
NDAQ (NDAQ) reports in 86 days, with the next report estimated for 01/21/2027. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 2.3% on average — the market has been roughly fair on NDAQ's earnings risk. Fundamentals into the print: EPS up 31.5% year-over-year, revenue up 22.2%. QuantLogix's live 5-factor engine currently reads NDAQ as a buy at 74/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →